You are here

  • Home
  • Archive
  • Volume 32, Issue Suppl 2
  • 2022-RA-1306-ESGO Effect of the COVID-19 pandemic on primary therapy and oncologic outcomes in women with advanced stage tubo-ovarian carcinoma in a tertiary cancer center

Citation Tools

Article menu

Download PDFPDF

Ovarian cancer
2022-RA-1306-ESGO Effect of the COVID-19 pandemic on primary therapy and oncologic outcomes in women with advanced stage tubo-ovarian carcinoma in a tertiary cancer center
Free

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Eriksson AGZ, Idland RK, Hoffmann LE, et al
2022-RA-1306-ESGO Effect of the COVID-19 pandemic on primary therapy and oncologic outcomes in women with advanced stage tubo-ovarian carcinoma in a tertiary cancer center
International Journal of Gynecologic Cancer 2022;32:A320-A321.